The Prevalence and Diagnostic Utility of Binding, Blocking, and Modulating Antibodies in Ocular Myasthenia

Update item information
Identifier 20200310_nanos_posters_259
Title The Prevalence and Diagnostic Utility of Binding, Blocking, and Modulating Antibodies in Ocular Myasthenia
Creator Samia Nawaz, Joseph Chacko
Subject Myasthenia, Ocular Motility, Neuro-ophth & Systemic Disease (eg. MS, MG, Thyroid), Diagnostic Tests (ERG, VER, OCT, HRT, mfERG, etc), Eyelid & Adnexal Disease, Miscellaneous
Description Myasthenia gravis (MG) is characterized by the presence of auto-antibodies against the acetylcholine receptor (AChR). One can test for several types of AChR antibodies to make a successful MG diagnosis. This study aimed to examine whether antibody testing can be streamlined to what is crucial for diagnosis and whether prednisone and/or pyridostigmine were correlated with conversion from ocular to systemic MG.
Relation is Part of NANOS Annual Meeting 2020: Poster Session II: Scientific Advancements
Contributor Primary Samia Nawaz
Contributor Secondary Joseph Chacko
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2020-03
Format application/pdf
Source 2020 North American Neuro-Ophthalmology Society Annual Meeting
Rights Management Copyright 2020. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Language eng
ARK ark:/87278/s63r63dx
Setname ehsl_novel_nam
Date Created 2020-04-21
Date Modified 2020-05-28
ID 1542126
Reference URL https://collections.lib.utah.edu/ark:/87278/s63r63dx
Back to Search Results